These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17922459)

  • 1. Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examination.
    Chechlinska M; Kaminska J; Markowska J; Kramar A; Steffen J
    Int J Biol Markers; 2007; 22(3):172-80. PubMed ID: 17922459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
    Candido Dos Reis F; Moreira de Andrade J; Bighetti S
    Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses.
    Tanir HM; Ozalp S; Yalcin OT; Colak O; Akcay A; Senses T
    Eur J Gynaecol Oncol; 2003; 24(3-4):271-4. PubMed ID: 12807238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in peritoneal fluid of ovarian neoplasms.
    de Lima CA; Silva Rodrigues IS; Martins-Filho A; Côbo Micheli D; Martins Tavares-Murta B; Candido Murta EF; Simões Nomelini R
    J Obstet Gynaecol; 2020 Apr; 40(3):401-405. PubMed ID: 31476946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin 7.
    Lambeck AJ; Crijns AP; Leffers N; Sluiter WJ; ten Hoor KA; Braid M; van der Zee AG; Daemen T; Nijman HW; Kast WM
    Clin Cancer Res; 2007 Apr; 13(8):2385-91. PubMed ID: 17438097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of Ovarian Cancer.
    Rodrigues ISS; Martins-Filho A; Micheli DC; Lima CA; Tavares-Murta BM; Murta EFC; Nomelini RS
    Immunol Invest; 2020 Jul; 49(5):510-521. PubMed ID: 31755326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer.
    Gorelik E; Landsittel DP; Marrangoni AM; Modugno F; Velikokhatnaya L; Winans MT; Bigbee WL; Herberman RB; Lokshin AE
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):981-7. PubMed ID: 15824174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [-Cytokine level in malignant ascites and peripheral blood of patients with advanced ovarian carcinoma-].
    Radke J; Schmidt D; Böhme M; Schmidt U; Weise W; Morenz J
    Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):83-7. PubMed ID: 8647364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
    Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
    Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of apoptosis and Fas expression of peritoneal fluid and peripheral blood T lymphocytes in patients with epithelial ovarian cancer and their relationship with CA125].
    Ma YX; Ye F; Chen HZ; Lü WG; Xie X
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):734-9. PubMed ID: 17565840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B; Reich R; Kopolovic J; Berner A; Nesland JM; Kristensen GB; Tropé CG; Bryne M; Risberg B; van de Putte G; Goldberg I
    Clin Exp Metastasis; 2002; 19(2):135-44. PubMed ID: 11964077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
    Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
    Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential tumor microenvironment in human ovarian cystic tumors.
    Tavares Murta BM; Cunha Fde Q; Miranda R; Adad SJ; Murta EF
    Tumori; 2004; 90(5):491-7. PubMed ID: 15656335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors.
    Punnonen R; Teisala K; Kuoppala T; Bennett B; Punnonen J
    Cancer; 1998 Aug; 83(4):788-96. PubMed ID: 9708947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer.
    Yüce K; Baykal C; Genç C; Al A; Ayhan A
    Eur J Gynaecol Oncol; 2001; 22(3):228-32. PubMed ID: 11501779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor in ovarian cyst fluid.
    Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; Boonstra H; Sweep CG
    Cancer; 2001 Jan; 91(2):371-7. PubMed ID: 11180084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of CA 125 levels in serum, peritoneal fluid and tumor in women with ovarian cancer].
    Markowska J; Wilkoszarska J
    Ginekol Pol; 1996 Jul; 67(7):352-6. PubMed ID: 9138997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
    Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
    Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma.
    Sevinc A; Camci C; Turk HM; Buyukberber S
    Oncology; 2003; 65(1):1-6. PubMed ID: 12837976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.